RE:RE:RE:RE:RE:Takeda acquiring Nimbus Therapeutics subsid for US$4 BillionAt the beginning of the week Nimbus Lakshimi was valued at US$ 0.00. Yesterday Nimbus Lakshimi was acquired for a total of US$6.0 Billion that included US$4 Billion in cash upfront.